Affinia Therapeutics

Affinia Therapeutics is a clinical-stage biotechnology company in Waltham, Massachusetts pioneering next-generation adeno-associated virus (AAV) gene therapies. Using AI and structural modeling to rationally design novel capsids that better target tissues for improved safety and effectiveness, Affinia develops therapeutic cargoes for devastating rare and prevalent diseases of the heart and the nervous system. Its lead program, AFTX-201, targets BAG3-associated dilated cardiomyopathy and is being evaluated in the UPBEAT trial. Affinia Therapeutics is a portfolio company of GV (Google Ventures). This company profile carries no public API surface; it is tracked in the API Evangelist network for identity and demand signal.

Affinia Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Therapy, and AAV.

Affinia Therapeutics’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyLife SciencesBiotechnologyGene TherapyAAVRare DiseaseCardiologyPharmaceuticalsClinical Stage

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.0/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/affinia-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: affinia-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/affinia-therapeutics.png
name: Affinia Therapeutics
description: Affinia Therapeutics is a clinical-stage biotechnology company in Waltham, Massachusetts pioneering next-generation
  adeno-associated virus (AAV) gene therapies. Using AI and structural modeling to rationally design novel capsids that better
  target tissues for improved safety and effectiveness, Affinia develops therapeutic cargoes for devastating rare and prevalent
  diseases of the heart and the nervous system. Its lead program, AFTX-201, targets BAG3-associated dilated cardiomyopathy
  and is being evaluated in the UPBEAT trial. Affinia Therapeutics is a portfolio company of GV (Google Ventures). This company
  profile carries no public API surface; it is tracked in the API Evangelist network for identity and demand signal.
url: https://raw.githubusercontent.com/api-evangelist/affinia-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Therapy
- AAV
- Rare Disease
- Cardiology
- Pharmaceuticals
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://affiniatx.com/
- type: Blog
  url: https://affiniatx.com/our-news/
- type: Support
  url: https://affiniatx.com/contact-us/
- type: PrivacyPolicy
  url: https://affiniatx.com/privacy-policy/
- type: TermsOfService
  url: https://affiniatx.com/terms-of-use/
- type: DomainSecurity
  url: security/affinia-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence